162
Views
7
CrossRef citations to date
0
Altmetric
Articles

Crystal structure, antibacterial activity and nanoparticles of Cd(II) complex derived from dithiophosphonate ligand

, , &
Pages 369-374 | Received 05 May 2017, Accepted 02 Jan 2018, Published online: 25 Jan 2018
 

GRAPHICAL ABSTRACT

ABSTRACT

The binuclear complex of the type Cd2(HL)4 was isolated from the reaction of cadmium(II) nitrate and dithiophosphonate ligands of the type R1R2PSSH (R1 = CH3OC6H4 and R2 = (CH3)2CHCH2CH2O). The crystal structure of bis-{bis-[O-3-methylbutyl (4-methoxyphenyl) dithiophosphonato] cadmium(II)}, Cd2(HL)4, has been determined by means of single-crystal X-ray diffraction methods. The cadmium is tetra-coordinated structure and constitutes a nearly planar geometry with the atoms on the PS2 group of the ligand. The nanoparticles of the complex were also prepared by ultrasonication, and their SEM micrographs indicated identical spherical morphologies with particles sizes about 32–39 nm. The complex and ligand were additionally tested in view of their antibacterial properties. The cadmium(II) dithiophosphonato complex was found to be more active against E. coli and S. aureus than free ligand.

Acknowledgements

We are grateful to University of Ardabil Payamenoor and Islamic Azad Germi University for supporting this research. PMc thanks NUI Galway University for support of the NUI Galway Crystallography Laboratory.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.